Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions
Glioma is often referred to as one of the most dreadful central nervous system (CNS)-specific
tumors with rapidly-proliferating cancerous glial cells, accounting for nearly half of the brain …
tumors with rapidly-proliferating cancerous glial cells, accounting for nearly half of the brain …
Pharmaceutical formulations with P-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability
P-glycoprotein (P-gp) is crucial in the active transport of various substrates with diverse
structures out of cells, resulting in poor intestinal permeation and limited bioavailability …
structures out of cells, resulting in poor intestinal permeation and limited bioavailability …
Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance
Gastric cancer (GC) results from deregulated cell growth in the stomach. Despite significant
efforts and recent advancements in the treatment of gastric cancer, it remains a life …
efforts and recent advancements in the treatment of gastric cancer, it remains a life …
Co-delivery of curcumin and paclitaxel by “core-shell” targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer
MD Zhao, JQ Li, FY Chen, W Dong… - International journal …, 2019 - Taylor & Francis
Background Ovarian cancer is a common malignancy in the female reproductive system with
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …
Advancements in redox-sensitive micelles as nanotheranostics: a new horizon in cancer management
A Sikder, G Vambhurkar, E Amulya… - Journal of Controlled …, 2022 - Elsevier
Abstract World Health Organisation (WHO) delineated cancer as one of the foremost
reasons for mortality with 10 million deaths in the year 2020. Early diagnosis and effective …
reasons for mortality with 10 million deaths in the year 2020. Early diagnosis and effective …
[HTML][HTML] Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
X Sun, P Zhao, J Lin, K Chen, J Shen - Cancer Drug Resistance, 2023 - ncbi.nlm.nih.gov
Cancer is currently one of the most intractable diseases causing human death. Although the
prognosis of tumor patients has been improved to a certain extent through various modern …
prognosis of tumor patients has been improved to a certain extent through various modern …
Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents
L Cabeza, G Perazzoli, C Mesas, C Jiménez-Luna… - AAPS …, 2020 - Springer
Colorectal cancer (CRC) is the third most common cancer worldwide. Its poor response to
current treatment options in advanced stages and the need for efficient diagnosis in early …
current treatment options in advanced stages and the need for efficient diagnosis in early …
Overcoming colloidal nanoparticle aggregation in biological milieu for cancer therapeutic delivery: Perspectives of materials and particle design
SH Lim, TW Wong, WX Tay - Advances in Colloid and Interface Science, 2024 - Elsevier
Nanoparticles as cancer therapeutic carrier fail in clinical translation due to complex
biological environments in vivo consisting of electrolytes and proteins which render …
biological environments in vivo consisting of electrolytes and proteins which render …
Polymeric micelles in cancer immunotherapy
Cancer immunotherapies have generated some miracles in the clinic by orchestrating our
immune system to combat cancer cells. However, the safety and efficacy concerns of the …
immune system to combat cancer cells. However, the safety and efficacy concerns of the …
Acidic pH-Triggered Release of Doxorubicin from Ligand-Decorated Polymeric Micelles Potentiates Efficacy against Cancer Cells
S Maitra Roy, S Barman, P Kishore… - ACS Applied Nano …, 2023 - ACS Publications
Current chemotherapeutic strategies against various intractable cancers are futile due to
inefficient delivery, poor bioavailability, and inadequate accumulation of anticancer drugs in …
inefficient delivery, poor bioavailability, and inadequate accumulation of anticancer drugs in …